{"title": "Medicines and Healthcare products Regulatory Agency", "author": null, "url": "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency", "hostname": "gov.uk", "description": "The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care .", "sitename": "GOV.UK", "date": "2023-09-08", "cleaned_text": "Medicines and Healthcare products Regulatory Agency Regulatory Agency - [Alerts, recalls and safety information: medicines and medical devices](https://www.gov.uk/drug-device-alerts) - [Drug Safety Update](https://www.gov.uk/drug-safety-update) - [Yellow Card: Report a problem with a medicine or medical device](https://www.gov.uk/yellowcard) - [Marketing authorisations and licensing guidance](https://www.gov.uk/medicines-medical-devices-blood/marketing-authorisations-variations-licensing) - [Product information medicines](https://www.gov.uk/guidance/find-product-information-about-medicines) - [Medical devices regulation and safety](https://www.gov.uk/medicines-medical-devices-blood/medical-devices-regulation-safety) - [Latest information services and information](https://www.gov.uk/government/collections/services-and-information) Featured [Berkshire couple receive prison sentence for illegal possession and supply of \u00a31.6m of unlicensed medicines](/government/news/berkshire-couple-receive-prison-sentence-for-illegal-possession-and-supply-of-16m-of-unlicensed-medicines) Press release Karina Filimonova and Andrejs Stolarovs were each sentenced at Southwark Crown Court to eight months in prison for the illegal possession and intent to supply unlicensed medicines, including prescription only medicines, valued at \u00a31.6m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA). [MHRA Corporate Plan: 2023 to 2026 and Business Plan: 2023 to 2024](/government/publications/mhra-corporate-plan-2023-to-2026) Corporate report These reports outline the MHRA's Corporate and Business Plans, detailing the agency's strategic direction over the next three years. [MHRA approves Pfizer/BioNTech's adapted COVID-19 vaccine (Comirnaty) that targets Omicron XBB.1.5](/government/news/mhra-approves-pfizerbiontechs-adapted-covid-19-vaccine-comirnaty-that-targets-omicron-xbb15) News story The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness [Guidance published on the new international regulatory recognition routes for medicines approvals](/government/news/guidance-published-on-the-new-international-regulatory-recognition-routes-for-medicines-approvals) News story The Medicines and Healthcare products Regulatory Agency (MHRA) has issued detailed guidance on the new International Recognition Procedure (IRP) for medicines manufacturers, including how to apply for a medicine licence. No action is currently needed from patients. No one should stop taking valproate without advice from their healthcare professional. The Medicines and Healthcare products Regulatory Agency (MHRA) has reinforced its safety guidance on the steps to take in anaphylaxis, after new figures obtained by the MHRA show more than 25,000 admissions to English hospitals for allergies and anaphylaxis in 2022-23, more than doubling in the last twenty years. Latest from the Medicines and Healthcare products Regulatory Agency What we do The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the [Department of Health and Social Care](/government/organisations/department-of-health-and-social-care). Follow us Documents Services [See all services](/search/services?organisations[]=medicines-and-healthcare-products-regulatory-agency&parent=medicines-and-healthcare-products-regulatory-agency) News and communications [See all news and communications](/search/news-and-communications?organisations[]=medicines-and-healthcare-products-regulatory-agency&parent=medicines-and-healthcare-products-regulatory-agency) Policy papers and consultations [See all policy papers and consultations](/search/policy-papers-and-consultations?organisations[]=medicines-and-healthcare-products-regulatory-agency&parent=medicines-and-healthcare-products-regulatory-agency) Transparency and freedom of information releases [See all transparency and freedom of information releases](/search/transparency-and-freedom-of-information-releases?organisations[]=medicines-and-healthcare-products-regulatory-agency&parent=medicines-and-healthcare-products-regulatory-agency) Our management Contact MHRA General enquiries 10 South Colonnade London E14 4PU United Kingdom Telephone 020 3080 6000 Fax 020 3118 9803 Office hours are Monday to Friday, 9am to 5pm. Media enquiries MHRA 10 South Colonnade London hours: 17:00) 07770 446 189 (17:00 - 08:30) Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at [https://www.twitter.com/mhragovuk](https://www.twitter.com/mhragovuk). Make an FOI request - Read about the Freedom of Information (FOI) Act and [how to make a request](https://www.gov.uk/make-a-freedom-of-information-request/the-freedom-of-information-act). - Check [our previous releases](/government/publications?departments[]=medicines-and-healthcare-products-regulatory-agency&publication_type=foi-releases)to see if we've already answered your question. - Make a new request by contacting us using the details below. Freedom of Information 10 South Colonnade London E14 4PU United Kingdom Corporate information Jobs and contracts Read our policy on "}